Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

HSR Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Opioid and High-Risk Prescribing Among Racial and Ethnic Minority Veterans.

Suda KJ, Boyer TL, Blosnich JR, Cashy JP, Hubbard CC, Sharp LK. Opioid and High-Risk Prescribing Among Racial and Ethnic Minority Veterans. American journal of preventive medicine. 2023 Nov 1; 65(5):863-875.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
   Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions



Abstract:

INTRODUCTION: The purpose of this study is to compare opioid prescribing and high-risk prescribing by race and ethnicity in a national cohort of U.S. veterans. METHODS: A cross-sectional analysis of veteran characteristics and healthcare use was performed on electronic health record data for 2018 Veterans Health Administration users and enrollees in 2022. RESULTS: Overall, 14.8% received an opioid prescription. The adjusted odds of being prescribed an opioid were lower for all race/ethnicity groups than for non-Hispanic White veterans, except for non-Hispanic multiracial (AOR = 1.03; 95% CI = 0.999, 1.05) and non-Hispanic American Indian/Alaska Native (AOR = 1.06; 95% CI = 1.03, 1.09) veterans. The odds of any day of overlapping opioid prescriptions (i.e., opioid overlap) were lower for all race/ethnicity groups than for the non-Hispanic White group, except for the non-Hispanic American Indian/Alaska Native group (AOR = 1.01; 95% CI = 0.96, 1.07). Similarly, all race/ethnicity groups had lower odds of any day of daily dose > 120 morphine milligram equivalents than the non-Hispanic White group, except for the non-Hispanic multiracial (AOR = 0.96; 95% CI = 0.87, 1.07) and non-Hispanic American Indian/Alaska Native (AOR = 1.06; 95% CI = 0.96, 1.17) groups. Non-Hispanic Asian veterans had the lowest odds for any day of opioid overlap (AOR = 0.54; 95% CI = 0.50, 0.57) and daily dose > 120 morphine milligram equivalents (AOR = 0.43; 95% CI = 0.36, 0.52). For any day of opioid-benzodiazepine overlap, all races/ethnicities had lower odds than non-Hispanic White. Non-Hispanic Black/African American (AOR = 0.71; 95% CI = 0.70, 0.72) and non-Hispanic Asian (AOR = 0.73; 95% CI = 0.68, 0.77) veterans had the lowest odds of any day of opioid-benzodiazepine overlap. CONCLUSIONS: Non-Hispanic White and non-Hispanic American Indian/Alaska Native veterans had the greatest likelihood to receive an opioid prescription. When an opioid was prescribed, high-risk prescribing was more common in White and American Indian/Alaska Native veterans than in all other racial/ethnic groups. As the nation's largest integrated healthcare system, the Veterans Health Administration can develop and test interventions to achieve health equity for patients experiencing pain.





Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.